Menu
Recruiting NCT06455488

MANAGE-VT Registry - MANAGEment of Ventricular Tachycardia Outcomes Registry

— Observational Ventricular Tachycardia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Ventricular Tachycardia Ablation, ICD Implant, Antiarrhythmic drug, EKG.
Who it may be relevant to
Registry conditions: Ventricular Tachycardia. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

MANAGEment of Ventricular Tachycardia Outcomes Registry

Overview

Data collection registry for patients with ventricular tachycardia to help physicians give better care for patients clinically and procedurally.

Detailed description

After consent from a patient the research team will input patients data from many different categories. There is a link to the PDF for the consent form, a patients anticoagulant medications will be assessed, their ventricular tachycardia (VT) history will be inputted, and their date of birth and zip code will inputted. The research team will then input any EKG's, echocardiograms, VT ablations, ICD's, S-ICD's, lab results, and comorbidities.

Interventions

  • Procedure Ventricular Tachycardia Ablation
    This is a surgical ablation meant to reset patients irregular rhythm back to sinus.
  • Device ICD Implant
    A pacemaker or defibrillator implant to prevent SCD
  • Drug Antiarrhythmic drug
    Drug therapies
  • Diagnostic test EKG
    Monitoring EKG testing done on registry patients
  • Diagnostic test Cardioversion
    Monitoring cardioversions on registry patients
  • Diagnostic test Echocardiogram
    Monitoring echocardiogram testing done on patients

Primary outcome measures

  • Recurrence of Ventricular Tachycardia [Time frame: July 20, 2020 - Present]
  • Number of Participants with Risk of Sudden Cardiac Death [Time frame: July 20, 2020 - Present]
  • Prevent Risk of Stroke [Time frame: July 20, 2020 - Present]

Eligibility criteria

Inclusion criteria

  • Must be at least 18 years old
  • Must not be

Exclusion criteria

\-

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • Corvita Science Foundation — Chicago

Identifiers

NCT: NCT06455488 · 2020-CSF-00300

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗